-

Cushman & Wakefield Announces an Amendment and Extension of Credit Facility

CHICAGO--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK), a leading global real estate services firm, today announced that the firm has amended its current Credit Agreement to increase the revolving commitments from $1.0 billion to $1.1 billion and has also extended the maturity date for the revolving credit facility from August 21, 2023 to April 28, 2027. All other terms are substantially similar to the existing credit facility.

In addition, the amendment reflects Cushman & Wakefield’s commitment to environmental, social and governance (ESG) by adding incentives linked to sustainability features based on the firm’s greenhouse gas (GHG) emission targets. These targets include:

  • Reducing GHG emissions across our corporate offices and operations 50% by 2030.
  • Partnering with the firm’s clients (representing 70% of its scope 3 value chain emissions) to set their own science-based targets by 2025.

“We are pleased to have completed the amendment of our credit facility and appreciate the strong support and commitment from our bank partners,” said Neil Johnston, Chief Financial Officer of Cushman & Wakefield. “Additionally, we are proud to align our sustainability commitments with our credit facility, demonstrating our commitment to ESG and the vital role we play in shaping a sustainable future for the commercial real estate industry.”

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global real estate services firm that delivers exceptional value for real estate occupiers and owners. Cushman & Wakefield is among the largest real estate services firms with approximately 50,000 employees in over 400 offices and approximately 60 countries. In 2021, the firm had revenue of $9.4 billion across core services of property, facilities and project management, leasing, capital markets, and valuation and other services. To learn more, visit www.cushmanwakefield.com or follow @CushWake on Twitter.

Contacts

INVESTOR RELATIONS:
Len Texter

Investor Relations
+1 312 338 7860
IR@cushwake.com

MEDIA CONTACT:
Aixa Velez
Corporate Communications
+1 312 424 8195
aixa.velez@cushwake.com

Cushman & Wakefield

NYSE:CWK

Release Summary
Cushman & Wakefield Announces an Amendment and Extension of Credit Facility
Release Versions

Contacts

INVESTOR RELATIONS:
Len Texter

Investor Relations
+1 312 338 7860
IR@cushwake.com

MEDIA CONTACT:
Aixa Velez
Corporate Communications
+1 312 424 8195
aixa.velez@cushwake.com

More News From Cushman & Wakefield

Cushman & Wakefield: U.S. Legal Sector Leasing Hits Record 7.3 Million Square Feet in Q2 2026 as Law Firms Expand Footprints

NEW YORK--(BUSINESS WIRE)--U.S. legal sector leasing reached a quarterly record of 7.3 million square feet (sf) in the second quarter of 2026, surpassing the previous quarterly high by 23%, according to a new report from Cushman & Wakefield. First-half legal leasing reached nearly 12.2 million sf, up 17% year over year, as law firm demand continued to contribute to the recovery in U.S. office leasing. “The legal sector is showing a clear preference for larger footprints, with expansion acti...

Cushman & Wakefield Releases 2026 Data Center Development Cost Guide, Citing 21% Rise in Per-MW Construction Costs

NEW YORK--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK), a leading global commercial real estate services firm, has published its 2026 Data Center Development Cost Guide, revealing that data center construction costs have risen an average of 21% per megawatt (MW) since the previous edition was published in the fourth quarter of 2024. Covering markets across the United States and Canada, the guide provides a comprehensive overview of data center development economics spanning land acquisi...

Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows

NEW YORK--(BUSINESS WIRE)--The U.S. life sciences real estate sector is moving toward a gradual rebalancing as development activity contracts, investment sales recover and funding conditions strengthen, according to the latest Life Sciences Update from Cushman & Wakefield. While elevated vacancy and softer rents continue to weigh on near-term fundamentals, a reduced construction pipeline and improving demand indicators are positioning the market for healthier long-term growth. U.S. life sci...
Back to Newsroom